vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
Globalstar, Inc. is the larger business by last-quarter revenue ($72.0M vs $38.3M, roughly 1.9× ImmunityBio, Inc.). Globalstar, Inc. runs the higher net margin — -16.1% vs -161.8%, a 145.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 17.6%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
GSAT vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $38.3M |
| Net Profit | $-11.6M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | -0.5% | -169.0% |
| Net Margin | -16.1% | -161.8% |
| Revenue YoY | 17.6% | 407.0% |
| Net Profit YoY | 76.9% | -4.7% |
| EPS (diluted) | $-0.11 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $38.3M | ||
| Q3 25 | $73.8M | $32.1M | ||
| Q2 25 | $67.1M | $26.4M | ||
| Q1 25 | $60.0M | $16.5M | ||
| Q4 24 | $61.2M | $7.6M | ||
| Q3 24 | $72.3M | $6.1M | ||
| Q2 24 | $60.4M | — | ||
| Q1 24 | $56.5M | — |
| Q4 25 | $-11.6M | $-61.9M | ||
| Q3 25 | $1.1M | $-67.3M | ||
| Q2 25 | $19.2M | $-92.6M | ||
| Q1 25 | $-17.3M | $-129.6M | ||
| Q4 24 | $-50.2M | $-59.2M | ||
| Q3 24 | $9.9M | $-85.7M | ||
| Q2 24 | $-9.7M | — | ||
| Q1 24 | $-13.2M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.5% | -169.0% | ||
| Q3 25 | 13.8% | -173.5% | ||
| Q2 25 | 9.2% | -269.8% | ||
| Q1 25 | -14.2% | -390.1% | ||
| Q4 24 | -6.9% | -919.0% | ||
| Q3 24 | 13.0% | -1314.3% | ||
| Q2 24 | -2.4% | — | ||
| Q1 24 | -8.3% | — |
| Q4 25 | -16.1% | -161.8% | ||
| Q3 25 | 1.5% | -209.8% | ||
| Q2 25 | 28.6% | -350.3% | ||
| Q1 25 | -28.9% | -784.9% | ||
| Q4 24 | -82.1% | -783.4% | ||
| Q3 24 | 13.7% | -1404.0% | ||
| Q2 24 | -16.0% | — | ||
| Q1 24 | -23.4% | — |
| Q4 25 | $-0.11 | $-0.06 | ||
| Q3 25 | $-0.01 | $-0.07 | ||
| Q2 25 | $0.13 | $-0.10 | ||
| Q1 25 | $-0.16 | $-0.15 | ||
| Q4 24 | $-0.57 | $-0.08 | ||
| Q3 24 | $0.00 | $-0.14 | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $242.8M |
| Total DebtLower is stronger | $483.8M | — |
| Stockholders' EquityBook value | $355.7M | $-500.5M |
| Total Assets | $2.3B | $501.9M |
| Debt / EquityLower = less leverage | 1.36× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $242.8M | ||
| Q3 25 | $346.3M | $257.8M | ||
| Q2 25 | $308.2M | $153.7M | ||
| Q1 25 | $241.4M | $61.6M | ||
| Q4 24 | $391.2M | $149.8M | ||
| Q3 24 | $51.9M | $130.4M | ||
| Q2 24 | $64.3M | — | ||
| Q1 24 | $59.3M | — |
| Q4 25 | $483.8M | — | ||
| Q3 25 | $508.6M | — | ||
| Q2 25 | $491.5M | — | ||
| Q1 25 | $502.7M | — | ||
| Q4 24 | $511.4M | — | ||
| Q3 24 | $394.4M | — | ||
| Q2 24 | $393.1M | — | ||
| Q1 24 | $398.7M | — |
| Q4 25 | $355.7M | $-500.5M | ||
| Q3 25 | $364.8M | $-524.3M | ||
| Q2 25 | $360.9M | $-570.7M | ||
| Q1 25 | $344.3M | $-591.4M | ||
| Q4 24 | $358.9M | $-489.1M | ||
| Q3 24 | $394.1M | $-745.1M | ||
| Q2 24 | $383.0M | — | ||
| Q1 24 | $377.1M | — |
| Q4 25 | $2.3B | $501.9M | ||
| Q3 25 | $2.2B | $519.0M | ||
| Q2 25 | $1.9B | $402.1M | ||
| Q1 25 | $1.7B | $303.8M | ||
| Q4 24 | $1.7B | $382.9M | ||
| Q3 24 | $917.6M | $364.6M | ||
| Q2 24 | $926.2M | — | ||
| Q1 24 | $917.0M | — |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $-70.4M | ||
| Q3 25 | $236.0M | $-68.9M | ||
| Q2 25 | $157.9M | $-79.7M | ||
| Q1 25 | $51.9M | $-85.9M | ||
| Q4 24 | $340.7M | $-85.1M | ||
| Q3 24 | $32.0M | $-98.8M | ||
| Q2 24 | $36.7M | — | ||
| Q1 24 | $29.8M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 45.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 216.53× | — | ||
| Q2 25 | 8.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
IBRX
Segment breakdown not available.
